Doctors from NYU Langone Medical Center: Langone This study provides the first in vivo evidence that zinc sulfate in combination with hydroxychloroquine may play a role in therapeutic management for COVID-19.


Abstract:
Background: COVID-19 has rapidly emerged as a pandemic infection that has caused significant mortality and economic losses. Potential therapies and means of prophylaxis against COVID-19 are urgently needed to combat this novel infection. As a result of in vitro evidence suggesting zinc sulfate may be efficacious against COVID-19, our hospitals began using zinc sulfate as add-on therapy to hydroxychloroquine and azithromycin. We performed a retrospective observational study to compare hospital outcomes among patients who received hydroxychloroquine and azithromycin plus zinc versus hydroxychloroquine and azithromycin alone. Methods: Data was collected from electronic medical records for all patients being treated with admission dates ranging from March 2, 2020 through April 5, 2020. Initial clinical characteristics on presentation, medications given during the hospitalization, and hospital outcomes were recorded. Patients in the study were excluded if they were treated with other investigational medications. Results: The addition of zinc sulfate did not impact the length of hospitalization, duration of ventilation, or ICU duration. In univariate analyses, zinc sulfate increased the frequency of patients being discharged home, and decreased the need for ventilation, admission to the ICU, and mortality or transfer to hospice for patients who were never admitted to the ICU. After adjusting for the time at which zinc sulfate was added to our protocol, an increased frequency of being discharged home (OR 1.53, 95% CI 1.12-2.09) reduction in mortality or transfer to hospice remained significant (OR 0.449, 95% CI 0.271-0.744). Conclusion: This study provides the first in vivo evidence that zinc sulfate in combination with hydroxychloroquine may play a role in therapeutic management for COVID-19.

Source:
https://www.researchgate.net/publication/341254876_Hydroxychloroquine_and_azithromycin_plus_zinc_vs_hydroxychloroquine_and_azithromycin_alone_outcomes_in_hospitalized_COVID-19_patients

Popular Posts in the Last 7 Days

The big question for French scientists and intellectuals:

Groq on miRNAs and retroviruses.

New cartoon

Dr. Konstance Knox explains why HHV-6 may be the key to dealing with AIDS.

Thyroiditis: One of HHV-6's 50 Shades of Non-HIV AIDS

The Big Medical Story the Media is Ignoring

Popular Post in the Last 30 Days

The only thing we have to fear is fear itself.

Dr. Konstance Knox explains why HHV-6 may be the key to dealing with AIDS.

Is there a connection between HHV-8 and African Swine Fever in Sardinia? Does it have implications for ASFV in the Western Hemisphere? "The 19R Protein of HHV-6 has significant amino acid sequence homology . . . to a protein encoded by African Swine Fever Virus."

Does the Joseph Fair mystery suggest that Covid-19 might not be caused by SARS-CoV-2? Is it just a biomarker?

Popular Posts from the Last Year

Ablashi discusses HHV-6, AIDS, Alzheimer's, and Chronic Fatigue Syndrome

Oral Kaposi's Sarcoma looks like the Crimson Crescents in Chronic Fatigue Syndrome patients.

Dr. Bhupesh Prusty and Professor Thomas Rudel discuss their HHV-6 research

Why HIV should be referred to as "a red herring."

Dr. Rebecca Culshaw Smith's book is discussed on Twitter

Anthony Fauci was part of the gang that silenced and destroyed Judy Mikovits.

All Time Most Popular Posts

Dr. Bhupesh Prusty and Professor Thomas Rudel discuss their HHV-6 research

Anthony Fauci was part of the gang that silenced and destroyed Judy Mikovits.

Was Judy Mikovits destroyed because her XMRV work would have ultimately shown HIV is a total fraud?

Is Chronic Fatigue Syndrome the other AIDS epidemic in the gay community?